BG98971A - Стабилизиран радиофармацевтичен кит - Google Patents

Стабилизиран радиофармацевтичен кит

Info

Publication number
BG98971A
BG98971A BG98971A BG9897194A BG98971A BG 98971 A BG98971 A BG 98971A BG 98971 A BG98971 A BG 98971A BG 9897194 A BG9897194 A BG 9897194A BG 98971 A BG98971 A BG 98971A
Authority
BG
Bulgaria
Prior art keywords
radiopharmaceutical kit
stabilized radiopharmaceutical
kit
radiopharmaceutical
components
Prior art date
Application number
BG98971A
Other languages
Bulgarian (bg)
English (en)
Inventor
Mark Derosch
Edward Deutsch
Mary Dyszlewski
Dennis Nosco
Original Assignee
Mallinckrodt Medical,Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Medical,Inc. filed Critical Mallinckrodt Medical,Inc.
Publication of BG98971A publication Critical patent/BG98971A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
BG98971A 1992-02-14 1994-08-11 Стабилизиран радиофармацевтичен кит BG98971A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/836,644 US5300280A (en) 1992-02-14 1992-02-14 Stabilized radiopharmaceutical kits
PCT/US1993/001196 WO1993015765A1 (en) 1992-02-14 1993-02-09 Stabilized radiopharmaceutical kits

Publications (1)

Publication Number Publication Date
BG98971A true BG98971A (bg) 1995-06-30

Family

ID=25272404

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98971A BG98971A (bg) 1992-02-14 1994-08-11 Стабилизиран радиофармацевтичен кит

Country Status (15)

Country Link
US (2) US5300280A (cs)
EP (2) EP0625054B1 (cs)
JP (1) JPH07503960A (cs)
AT (1) ATE378073T1 (cs)
AU (1) AU3662493A (cs)
BG (1) BG98971A (cs)
CA (1) CA2129755C (cs)
DE (1) DE69334183T2 (cs)
FI (1) FI943724L (cs)
HU (1) HUT74566A (cs)
IL (1) IL104655A (cs)
NO (1) NO942899L (cs)
SK (1) SK96694A3 (cs)
WO (1) WO1993015765A1 (cs)
ZA (1) ZA93949B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
US5744120A (en) * 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
WO1994022496A1 (en) * 1993-03-31 1994-10-13 Mallinckrodt Medical, Inc. Radiopharmaceutical formulations having non-stannous reductants
US5993777A (en) * 1993-05-06 1999-11-30 Research Corporation Technologies, Inc. Benzamide compounds for cancer imaging and therapy
US6517811B2 (en) 1993-05-06 2003-02-11 Research Corporation Technologies, Inc. Compounds for cancer imaging and therapy
US5911970A (en) * 1993-05-06 1999-06-15 Research Corporation Technologies, Inc. Methods for cancer imaging and therapy using benzamine compounds
US5951964A (en) * 1993-06-04 1999-09-14 Diatide, Inc. Technetium-99m labeled peptides for imaging
FR2726765B1 (fr) * 1994-11-14 1996-12-20 Cis Bio Int Compositions radiopharmaceutiques comprenant un complexe d'inclusion d'une cyclodextrine et d'un acide gras radiohalogene
US5762903A (en) * 1995-03-10 1998-06-09 Korea Atomic Energy Research Institute Radioactive chitosan complex for radiation therapy
DE69733664T3 (de) 1996-04-19 2011-04-14 Grifols Inc. (n.d. Ges.d.Staates Delaware), Los Angeles Verfahren zur INaktivierung von Viren und Lyophilisierung von Blutproteinen
IT1289660B1 (it) * 1996-10-03 1998-10-16 Sorin Biomedica Diagnost Spa Procedimento per la riduzione di composti ossigenati del renio o del tecnezio
WO1998029139A1 (en) * 1996-12-25 1998-07-09 Gosudarstvenny Nauchny Tsentr Fiziko-Energetichesky Institut PREPARATION CONTAINING AN ORGANIC COMPOUND LABELLED WITH A β RADIONUCLIDE
US6905668B1 (en) 1998-09-25 2005-06-14 Tokyo Gas Company Limited Diagnostic agents for pancreatic exocrine function
NZ507949A (en) 1998-09-25 2002-03-01 Tokyo Gas Co Ltd C-13 or C-14 labelled fluorescein derivatives and diagnostic compositions
US6056941A (en) * 1999-07-28 2000-05-02 Bracco Research Usa Kit for the preparation of technetium TC 99m teboroxime myocardial perfusion agent
US20020146409A1 (en) * 2001-01-30 2002-10-10 Herring Steven W. Methods for stabilizing lyophilized blood proteins
JP2008503493A (ja) * 2004-06-17 2008-02-07 アナザオヘルス コーポレーション 腫瘍を破壊するための安定化され凍結乾燥された放射性薬剤
WO2006085941A1 (en) * 2004-06-17 2006-08-17 Anazaohealth Corporation Copper-complex isonitrile positron emission tomography (pet) imaging agent and method
US7229603B2 (en) * 2004-06-17 2007-06-12 Anazaohealth Corporation Stablilized and lyophilized radiopharmaceutical agents
GB0427392D0 (en) * 2004-12-15 2005-01-19 Amersham Plc Stabilised 99mTc compositions
US9321095B2 (en) 2010-06-30 2016-04-26 General Electric Company Apparatuses and methods for cutting porous substrates
GB201915206D0 (en) * 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219270A (ja) * 1983-05-30 1984-12-10 Wako Pure Chem Ind Ltd テトラゾリウム塩を含有する溶液の安定化方法
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
JPH064770B2 (ja) * 1984-07-31 1994-01-19 三菱電機株式会社 ジチオラト錯体−シクロデキストリン包接化合物の製造方法
ES8801168A1 (es) * 1984-11-02 1987-02-16 Johnson Matthey Plc Procedimiento para la obtencion de un compuesto de platino para utilizar en quimioterapia del cancer.
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US4714605A (en) * 1986-10-14 1987-12-22 E. R. Squibb & Sons, Inc. Technetium-99m labeled dioxime complexes
US4871836A (en) * 1987-10-13 1989-10-03 E. R. Squibb & Sons, Inc. Boronic acid adducts of rhenium and radioactive isotopes of rhenium dioxime complexes
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
CA1321192C (en) * 1988-04-20 1993-08-10 Abdul Majid Inclusion complexes of cyclodextrins by agglomeration
US5002754A (en) * 1988-06-15 1991-03-26 University Of Cincinnati Technetium (III/II) imaging agents
US5068227A (en) * 1989-01-18 1991-11-26 Cyclex, Inc. Cyclodextrins as carriers
US4917879A (en) * 1989-05-19 1990-04-17 University Of Cincinnati 99MTC(III) myocardial imaging agents that are effective in humans
US5026913A (en) * 1989-12-12 1991-06-25 Medi-Physics, Inc. Hydrocarbylphenyl diaminodithiol derivatives
US5080884A (en) * 1989-12-12 1992-01-14 Medi-Physics, Inc. Hydrocarbylphenyl diaminodithiol radionuclide complexes and their use in imaging
US5183653A (en) * 1990-04-13 1993-02-02 E. R. Squibb & Sons, Inc. Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds
US5112595A (en) * 1990-12-21 1992-05-12 Mallinckrodt Medical, Inc. 99MTC(III) myocardial imaging agents and method of use

Also Published As

Publication number Publication date
EP0625054A4 (en) 1996-04-17
HUT74566A (en) 1997-01-28
CA2129755A1 (en) 1993-08-15
EP0625054B1 (en) 2007-11-14
FI943724A7 (fi) 1994-08-12
NO942899L (no) 1994-08-04
WO1993015765A1 (en) 1993-08-19
SK96694A3 (en) 1995-03-08
DE69334183D1 (de) 2007-12-27
EP1690552A3 (en) 2008-07-02
ATE378073T1 (de) 2007-11-15
NO942899D0 (cs) 1994-08-04
FI943724A0 (fi) 1994-08-12
IL104655A0 (en) 1993-06-10
DE69334183T2 (de) 2008-11-06
IL104655A (en) 1998-06-15
US6428768B1 (en) 2002-08-06
ZA93949B (en) 1993-12-07
EP1690552A2 (en) 2006-08-16
JPH07503960A (ja) 1995-04-27
HU9402349D0 (en) 1994-10-28
CA2129755C (en) 2006-01-03
US5300280A (en) 1994-04-05
AU3662493A (en) 1993-09-03
FI943724L (fi) 1994-08-12
EP0625054A1 (en) 1994-11-23

Similar Documents

Publication Publication Date Title
BG98971A (bg) Стабилизиран радиофармацевтичен кит
DK0710228T3 (da) Hydraziner med N3S-konfiguration som radionuclidchelatorer
TR200101815T2 (tr) Sulu reaktif dolgu bileşimleri (I).
EP0313305A3 (en) Photoprotection compositions comprising chelating agents
LU90366I2 (fr) Nasonex
DK332684A (da) Modificerede protease-inhibitorer samt deres fremstilling og anvendelse
PT935609E (pt) Composicoes cristalizaveis que contem um complexo entre o dominio de protease ns3 do virus da hepatite c e ns4a cristais resultantes
DE69837324D1 (de) Behandlung der multiplen sklerose durch einnahme von copolymer-1
ATE178053T1 (de) N2s2-chelatoren des hydrazino-typs
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
DE69109689D1 (de) Eine feuchtigkeitshärtende einkomponenten-polysiloxanzuzammensetzung.
ATE331037T1 (de) Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff
UA27221C2 (uk) Ефіри циклогексеноноксиму та гербіцидний засіб
ATE187731T1 (de) Technetium-99m-komplexe zur verwendung als radiopharmazeutische mittel
EA199800534A1 (ru) ПРИМЕНЕНИЕ 2-ЭТИЛГЕКСИЛ-α-ЦИАНО-β, β-ДИФЕНИЛАКРИАТА ДЛЯ УЛУЧШЕНИЯ СТАБИЛЬНОСТИ КОСМЕТИЧЕСКИХ КОМПОЗИЦИЙ, СОДЕРЖАЩИХ П-МЕТИЛБЕНЗИЛИДЕНКАМФОРУВ СОЧЕТАНИИ С ДИБЕНЗОИЛМЕТАНОВЫМ ПРОИЗВОДНЫМ
DK1279677T3 (da) GD3-mimetiske peptider
YU41796A (sh) Smeše za poboljšanje podnošljivosti delotvornih beta-amino kiselina
DK0977871T3 (da) Neurotrypsin
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
IL124738A0 (en) Stabilized hydroxylamine solutions
TW334451B (en) Composition which can be crosslinked by light
SE9604439D0 (sv) New receptor
DE3882016D1 (de) Durch aminische orthoester stabilisierte zusammensetzungen.
DE60102704D1 (de) Trioxepan verbindungen
DE69227844D1 (de) Waschmittelzusammensetzungen